1. Home
  2. OLB vs RNAZ Comparison

OLB vs RNAZ Comparison

Compare OLB & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The OLB Group Inc.

OLB

The OLB Group Inc.

HOLD

Current Price

$0.43

Market Cap

7.7M

Sector

Technology

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$8.81

Market Cap

8.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLB
RNAZ
Founded
1993
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
8.5M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
OLB
RNAZ
Price
$0.43
$8.81
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$280.00
AVG Volume (30 Days)
351.4K
5.4K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
71.48
54.50
EPS
N/A
N/A
Revenue
$8,676,907.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.22
52 Week High
$2.50
$20.99

Technical Indicators

Market Signals
Indicator
OLB
RNAZ
Relative Strength Index (RSI) 37.90 43.58
Support Level $0.31 $8.37
Resistance Level $0.58 $11.62
Average True Range (ATR) 0.06 0.40
MACD -0.01 -0.00
Stochastic Oscillator 24.77 28.03

Price Performance

Historical Comparison
OLB
RNAZ

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: